Improvement in early function of the hepatic graft after treatment of the donor with N-acetylcysteine: Clinical study

Transplantation Proceedings

Volumn 29, Issue 8 A, 1997, Pages 3350-3352

  Regueira, F M ^a   Cienfuegos, J A ^a   Pardo, F ^a   Hernandez J L ^a   Diez Caballero A ^a   Sierra, A ^a   Nwose, E ^a   Espi A ^a   Baixauli J ^a   Rotellar, F ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ISOLATION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; SURVIVAL RATE;

ACETYLCYSTEINE; ADENOSINE; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASES; BILE; BILIRUBIN; GLUTATHIONE; GRAFT REJECTION; HUMANS; INSULIN; LIVER TRANSPLANTATION; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PROTHROMBIN TIME; RAFFINOSE; SURVIVAL RATE; TISSUE DONORS;

EID: 0031440608     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00938-X     Document Type: Conference Paper

References (7)

1. Beizi K, Jalau R, Plevris, et al: Liver Transplant Surg 3:137, 1997
2. Goode H, Webster N, Howdle et al: Hepatology 19:354, 1994
3. Dunne J, Davenport M, Williams R, et al: Transplantation 57:1161, 1994
4. Fukuzawa K, Emre S, Senyuz, et al: Transplantation 59:6, 1995
5. Harrison P, Wendau J, Gimson A, et al: N Engl J Med 324:1852, 1991
6. Bromley P, Cottau S, Hilmi I, et al: Br J Anaesth 75:352, 1995
7. Howard T, Goran B, Klintmalm G, et al: Transplantation 3:103, 1990